Will James > Osborne Clarke LLP > London, England > Lawyer Profile

Catering primarily to the private healthcare sector, Osborne Clarke LLP‘s life sciences and healthcare practice advises on a wide range of legal and regulatory matters; NHS procurement, digital health and health infrastructure are all key focal points for the firm. Richard Wilkinson and Will James chair the practice from the firm’s London office. Bristol-based Catherine Wolfenden leads the firm’s regulated procurement practice, where she frequently works with major NHS suppliers on various issues. Her Bristol colleague Simon Hancock’s practice focus encompasses PPP/PFI asset management matters and capital works. Kate Davies, whose procurement expertise extends to advising on compliance with new NHS net zero requirements, is also recommended.

A team noted for its deep sector expertise, Osborne Clarke LLP’s practice has recently been involved in mandates involving FRAND and SEP litigation. Experienced litigation specialist Arty Rajendra leads the department, while Tim Harris is noted for his expertise in the life sciences, pharma and biotech sectors. Will James bolsters the practice with his capabilities in handling litigation for large tech-driven companies, notably in the life sciences, electronics and medical devices fields. Trevor Crosse joined from Marks & Clerk in October 2022.

Osborne Clarke LLP acts for a varied client roster, notably including BioNTech, Turbine, and Advent Life Sciences. Practice co-head Will James is a patent litigator who regularly acts for biotech, electronics, and medical device companies in disputes; while co-head Matthew Edwards maintains a corporate-focused practice, and advises companies and investors on M&A and venture capital investments. Marcus Vass primarily advises digital health companies on outsourcings and privacy matters. Peter Rudd-Clarke has broad experience in defending product liability claims and handling regulatory compliance issues. Having joined the team from Marks & Clerk in October 2022, Trevor Crosse has deep knowledge of SPC disputes and exclusivity rights.